JO
TDACU

John Overdeck’s Translational Development Acquisition Corp Units TDACU Stock Holding History

John Overdeck’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-133,325
Closed -$1.37M – 4009
2025
Q2 		$1.37M Hold
133,325
– – ﹤0.01% 2067
2025
Q1 		$1.35M Hold
133,325
– – ﹤0.01% 1992
2024
Q4 		$1.34M Buy
+133,325
New +$1.34M ﹤0.01% 1985

Other funds holding TDACU

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

John Overdeck's TDACU Position: Q3 2025 in Review

John Overdeck sold out of Translational Development Acquisition Corp Units (TDACU) in Q3 2025, closing a stake of 133,325 shares — an estimated $1.37M sold.

John Overdeck first reported a position in TDACU in Q4 2024 and held it in 3 quarters. The position peaked at $1.37M in Q2 2025. 7 funds tracked by Wall St. Rank hold TDACU as of Q3 2025.

  • John Overdeck reported no remaining Translational Development Acquisition Corp Units position as of Q3 2025 after selling out during the quarter.
  • John Overdeck sold 133,325 Translational Development Acquisition Corp Units shares in Q3 2025, an estimated $1.37M.
  • John Overdeck first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 3 quarters.
  • John Overdeck's Translational Development Acquisition Corp Units position peaked at $1.37M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.